Orbimed Advisors - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 49 filers reported holding TALARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,064,000
-56.3%
235,995
-4.5%
0.02%
-51.3%
Q1 2022$2,433,000
-35.6%
247,2400.0%0.04%
-20.4%
Q4 2021$3,780,000
+12.7%
247,2400.0%0.05%
+32.4%
Q3 2021$3,353,000
-7.7%
247,2400.0%0.04%0.0%
Q2 2021$3,632,000247,2400.04%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 682,923$9,260,0001.85%
SECTORAL ASSET MANAGEMENT INC 814,163$11,040,0000.92%
Cormorant Asset Management, LP 1,215,847$16,349,0000.66%
Artal Group S.A. 2,064,262$27,991,0000.63%
Logos Global Management LP 507,923$6,887,0000.50%
Eventide Asset Management 1,561,092$20,686,0000.27%
Blackstone Inc. 8,089,315$109,691,0000.24%
Avidity Partners Management LP 455,000$6,170,0000.14%
HHLR ADVISORS, LTD. 761,885$10,331,0000.14%
VIKING GLOBAL INVESTORS LP 3,289,617$44,607,0000.12%
View complete list of TALARIS THERAPEUTICS INC shareholders